Antibiotic resistance and gyrA mutation affect the efficacy of 10-day sitafloxacin-metronidazole-esomeprazole therapy for Helicobacter pylori in penicillin allergic patients. (Q42284208)
Jump to navigation
Jump to search
scientific article published on 19 January 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antibiotic resistance and gyrA mutation affect the efficacy of 10-day sitafloxacin-metronidazole-esomeprazole therapy for Helicobacter pylori in penicillin allergic patients. |
scientific article published on 19 January 2017 |
Statements
Antibiotic resistance and gyrA mutation affect the efficacy of 10-day sitafloxacin-metronidazole-esomeprazole therapy for Helicobacter pylori in penicillin allergic patients (English)
Helicobacter pylori
1 reference
Hideki Mori
Hidekazu Suzuki
Juntaro Matsuzaki
Tatsuhiro Masaoka
19 January 2017
1 reference